LETTER
Coupling Reagent for Polyamine Solid-Phase Synthesis
2789
(10) Spectroscopic Data for Side Product 8
were cleaved from the resin and purified by preparative
HPLC.13 As shown in Table 2, the crosslink occurred ef-
ficiently with a variety of structurally diverse maleimides.
The small maleimides from entries 1–3 reacted smoothly
and the products were obtained in high purities. Entries 4–
7 showed that also bulkier maleimido building blocks
with a broad variation in polarity were tolerated.
1H NMR (MeOD, 400 MHz): d = 4.45 (dd, J1 = 9.1 Hz,
J2 = 5.7 Hz, 1 H), 3.57 (q, J = 7.3 Hz), 3.16 (dd, J1 = 17.9
Hz, J2 = 9.2 Hz, 1 H), 3.08 (t, J = 7.6 Hz, 2 H), 3.05 (t,
J = 7.7 Hz, 2H), 2.91 (dd, J1 = 17.9 Hz, J2 = 5.6 Hz, 1 H),
2.13 (m, 2 H), 1.17 (t, J = 7.2 Hz).
(11) Spectroscopic Data for Compound 9
1H NMR (MeOD, 400 MHz): d = 3.89 (dd, J1 = 9.1 Hz,
J2 = 2.9 Hz, 1 H), 3.52 (q, J = 7.2 Hz, 2 H), 3.38 (t, J = 7.1
Hz, 2 H), 3.19 (dd, J1 = 18.5 Hz, J2 = 9.1 Hz, 1 H), 3.03 (t,
J = 7.7 Hz, 2 H), 2.97 (dd, J1 = 13.4 Hz, J2 = 6.8 Hz, 1 H),
2.79 (dd, J1 = 13.5 Hz, J2 = 7.1 Hz, 1 H), 2.61 (t, J = 7.7 Hz,
2 H), 2.46 (dd, J1 = 18.6 Hz, J2 = 3.7 Hz, 1 H), 2.08 (tt,
J1 = 7.1 Hz, J2 = 7.1 Hz, 1 H), 2.01 (tt, J1 = 7.2 Hz, J2 = 7.2
Hz, 1 H), 1.13 (t, J = 7.2 Hz, 2 H). ESI-HRMS: m/z calcd for
C13H25N4O2S+: 301.1693; found: 301.1686.
The lower conversion rate in entry 7 (Table 2) is due to the
lower excess of the strongly fluorescent maleimido build-
ing block (1.7 equiv) to avoid the aggregation of the com-
pound on the resin.14 Nonreacted substrate can be
recovered.
In conclusion, we developed a protocol that allows the ap-
plication of 2-iminothiolane for the chemoselective cou-
pling of polyamines to maleimides for solid-phase
chemistry. This method displays a quick and mild method
that avoids both, laborious protection-group transforma-
tions and alkylation procedures, and allows the synthesis
of base- and acid-labile conjugates if carried out on highly
acid-labile alkoxytrityl resins.15
(12) Ethylmaleimide, phenylmaleimide, and 3-maleimido-
propionic acid were purchased from Sigma-Aldrich. The
maleimides from entries 4–6 were prepared by the following
procedure: 3-maleimidopropionic acid N-
hydroxysuccinimide ester (3 equiv) and DIPEA (1 equiv)
were dissolved in DMF, and amine (1 equiv) was added in
the same volume of THF. The suspension was stirred for 8 h
and THF was removed in vacuo. The remaining suspension
was partitioned between CH3Cl and H2O, and the organic
layer was washed with H2O (3 ×). The organic layer was
dried over Na2SO4, and the product was purified by flash
chromatography. The products were isolated in 47%, 49%,
and 35% yield and analyzed by HRMS and 1H NMR
spectroscopy. In entry 5, CH2Cl2 was used as solvent instead
of THF–DMF and DMAP (1 equiv) was added for additional
activation.
Acknowledgment
We would like to thank the DFG-Center for Functional Nanostruc-
tures (CFN), Karlsruhe, Prof. Bräse, Karlsruhe, and Prof. Sandhoff,
Bonn for financial support.
References and Notes
(13) Experimental Procedure
Alkoxytrityl resin (100 mg) loaded with tris-Aloc-spermine
(0.027 mmol, 1 equiv) were swollen in CH2Cl2 and a
solution of Pd(PPh3)4 (6 mg, 0.005 mmol, 0.2 equiv) and of
N,N¢-dimethylbarbituric acid (33 mg, 0.214 mmol, 8 equiv)
in CH2Cl2 (2 mL) were added. The suspension was agitated
for 16 h at 40 °C. The resin was alternately washed with a
solution of sodium N,N-dimethylaminodithiocarbamate in
CH2Cl2–MeOH (4:1) and MeOH (3 ×), THF and MeOH (3 ×),
and CH2Cl2 (3 ×). The resin was swollen in THF (1 mL) for
10 min and 2-iminothiolane (11 mg, 0.081 mmol, 3 equiv.)
in H2O (200 mL) was added. The suspension was agitated
for 2 min, then the respective maleimide (2 equiv) in THF
(800 mL) was added, and the suspension was agitated for
1 h. The resin was washed with H2O, THF, MeOH (3 ×), and
CH2Cl2 (3 ×). The crude product was cleaved from the resin
with 1% TFA in CH2Cl2. The filtrate was combined with the
filtrate of the CH2Cl2 and MeOH wash. In entry 5 the 5¢-
DMTr group was removed by quick treatment of the resin
with 1% TFA in CH2Cl2 and subsequent washing of the
polymer with a minimal amount of CH2Cl2–Et2O (2:1) until
the filtrate is clear. The product was washed from the resin
with CH2Cl2 and MeOH. The solvents were removed and the
remaining compound was purified by preparative HPLC on
C18 column with gradients of eluent A [95% TEAA (0.01 M,
pH 7.0)–5% MeCN] and eluant B [5% TEAA (0.01 M, pH
7.0)–95% MeCN), or with eluant A (95% H2O–5% MeCN–
0.1% AcOH) and eluant B (5% H2O–95% MeCN–0.1%
AcOH).
(1) For a review, see: Schepers U., Schmitz K., Hahn F., Bräse
S.; Angew. Chem. Int. Ed.; submitted
(2) Foerg, C.; Merkle, H.-P. J. Pharm. Sci. 2007, 97, 144.
(3) Hahn, F.; Schepers, U. In Combinatorial Chemistry on Solid
Supports, Vol. 278; Bräse, S., Ed.; Springer: Berlin /
Heidelberg, 2007, 135–208.
(4) (a) Manku, S.; Laplante, C.; Kopac, D.; Chan, T.; Hall, D. G.
J. Org. Chem. 2001, 66, 874. (b) Kan, T.; Kobayashi, H.;
Fukuyama, T. Synlett 2002, 1338. (c) Jönsson, D.
Tetrahedron Lett. 2002, 43, 4793. (d) Nash, I. A.; Bycroft,
B. W.; Chan, W. C. Tetrahedron Lett. 1996, 37, 2625.
(5) Hahn, F.; Schepers, U. J. Comb. Chem. 2008, 10, 267.
(6) (a) Traut, R. R.; Bollen, A.; Sun, T. T.; Hershey, J. W. B.;
Sundberg, J.; Pierce, L. R. Biochemistry 1973, 12, 3266.
(b) Jue, R.; Lambert, J. M.; Pierce, L. R.; Traut, R. R.
Biochemistry 1978, 17, 5399. (c) Miyata, K.; Kakizawa, Y.;
Nishiyama, N.; Harada, A.; Yamasaki, Y.; Koyama, H.;
Kataoka, K. J. Am. Chem. Soc. 2004, 126, 2355. (d) Tada,
T.; Mano, K.; Yoshida, E.; Tanala, N.; Kunugi, S. Bull.
Chem. Soc. Jpn. 2002, 75, 2247. (e) King, T. P.; Li, Y.;
Kochoumian, L. Biochemistry 1978, 17, 1499.
(7) Gruneich, J. A.; Diamond, S. L. J. Gene Med. 2007, 9, 381.
(8) (a) Bartlett, M. G.; Buscht, K. L. Biol. Mass Spec. 1994, 23,
353. (b) Singh, R.; Kats, L.; Blättler, W. A.; Lambert, J. M.
Anal. Biochem. 1996, 236, 114. (c) Mokotoff, M.;
Mocarski, Y. M.; Gentsch, B. L.; Miller, M. R.; Zhou, J. H.;
Chen, J.; Ball, E. D. J. Peptide Res. 2001, 57, 383.
(9) Spectroscopic Data for Side Product 6
(14) Characterization of the Products of Entries 1–7 (Table 2)
Entry 1: 1H NMR (400 MHz, MeOD): d = 1.14 (t, J = 7.2
Hz, 3 H), 1.79 (m, 4 H), 2.06 (tt, J1 = 7.7 Hz, J2 = 7.3 Hz,
4 H), 2.13 (m, 2 H), 2.47 (dd, J1 = 18.5 Hz, J2 = 3.9 Hz, 1 H),
2.62 (t, J = 7.7 Hz, 2 H), 2.80 (dt, J1 = 13.5 Hz, J2 = 7.0 Hz,
1 H), 2.98 (dt, J1 = 13.6 Hz, J2 = 6.8 Hz, 1 H), 3.00–3.15 (m,
1H NMR (MeOD, 400 MHz): d = 3.69 (t, J = 7.2 Hz, 2 H),
3.65 (t, J = 6.5 Hz, 2 H), 3.26 (t, J = 7.2 Hz, 2 H), 3.09 (t,
J = 7.5 Hz, 2 H), 2.44 (tt, J1 = 6.9 Hz, J2 = 6.8 Hz, 2 H), 2.18
(tt, J1 = 7.4 Hz, J2 = 7.4 Hz, 2 H). ESI-MS: m/z = 159.1
[M + H]+.
Synlett 2008, No. 18, 2785–2790 © Thieme Stuttgart · New York